Coles Group (ASX:COL) accepted the ranging of Calmer Co International's (ASX:CCO) new Fiji Kava-branded FZZR kava product as part of its latest range review, according to a Wednesday filing with the Australian bourse.
Calmer Co International expects the product, which will be regulated as a complementary medicine under the Therapeutic Goods Administration framework, to be distributed through Coles stores in October, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.